VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Dyne Therapeutics, Inc. (DYN) Total Return Calculator with Dividends Reinvested

Dyne Therapeutics, Inc.

Popular:

The total return for Dyne Therapeutics, Inc. (DYN) stock is +47.68% over the past 12 months. So far it's down 5.57% this year. The 5-year total return is -1.85%, meaning $10,000 invested in DYN stock 5 years ago would be worth $9,815 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in DYN 1 year ago, it would be worth $17,435 today — you'd have gained $7,435.

With Dividends Reinvested$17,435+74.35%

Price Only (No DRIP)$17,435+74.35%

Period2025-05-06 → 2026-05-05

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in DYN

1Y$14,768+$4,768 (+47.7%)47.7% CAGR

3Y$12,505+$2,505 (+25.1%)7.7% CAGR

5Y$9,815-$185 (-1.9%)-0.4% CAGR

10Y$7,310-$2,690 (-26.9%)-3.1% CAGR

15Y$7,310-$2,690 (-26.9%)-2.1% CAGR

20Y$7,310-$2,690 (-26.9%)-1.6% CAGR

30Y$7,310-$2,690 (-26.9%)-1.0% CAGR

Dyne Therapeutics, Inc. did not pay dividends during this period. Total return = price return.

Loading DYN total return...

As of 2026-05-06

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-5.57%	—	-5.57%	—	$9,443
1Y	+47.68%	47.68%	+47.68%	—	$14,768
3Y	+25.05%	7.74%	+25.05%	—	$12,505
5Y	-1.85%	-0.37%	-1.85%	—	$9,815
10Y	-26.90%	-3.09%	-26.90%	—	$7,310
15Y	-26.90%	-2.07%	-26.90%	—	$7,310
20Y	-26.90%	-1.55%	-26.90%	—	$7,310
30Y	-26.90%	-1.04%	-26.90%	—	$7,310

Risk & Highlights

Best Year+80.40%2024

Worst Year-37.45%2021

Max Drawdown-44.65%2025-06-10 → 2025-07-07 · Recovered 2025-10-14

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-15.57%	-15.57%	—	+0.41%	-16.0pp
2025	-23.17%	-23.17%	—	+16.64%	-39.8pp
2024	+80.40%	+80.40%	—	+24.00%	+56.4pp
2023	+13.68%	+13.68%	—	+24.81%	-11.1pp
2022	-5.54%	-5.54%	—	-19.95%	+14.4pp

DYN outperformed the S&P 500 by 19.24pp over the past year (+47.68% vs +28.44%).

Loading summary...

DYN Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
DYNDyne Therapeutics, Inc.	$2.9B	-4.8%	-5.6%	+47.7%	—	+25.1%	-1.9%	-26.9%
SRPTSarepta Therapeutics, Inc.	$2.3B	-4.4%	+2.3%	-65.8%	—	-83.4%	-70.1%	+30.0%
CRSPCRISPR Therapeutics AG	$4.9B	+6.6%	-2.6%	+39.2%	—	-6.1%	-54.0%	+271.8%
BMRNBioMarin Pharmaceutical Inc.	$10.2B	-5.3%	-10.4%	-14.2%	—	-44.9%	-31.5%	-34.1%
FOLDAmicus Therapeutics, Inc.	$4.5B	+0.3%	+1.5%	+121.9%	—	+19.3%	+51.1%	+121.9%
RAREUltragenyx Pharmaceutical Inc.	$2.5B	+9.4%	+6.0%	-35.7%	—	-47.0%	-76.4%	-60.0%
IONSIonis Pharmaceuticals, Inc.	$12.4B	+1.2%	-5.5%	+123.6%	—	+107.9%	+88.6%	+115.6%
ALNYAlnylam Pharmaceuticals, Inc.	$40.2B	-8.8%	-24.8%	+10.1%	—	+42.0%	+127.0%	+412.7%
ARWRArrowhead Pharmaceuticals, Inc.	$10.5B	+22.6%	+10.5%	+436.0%	—	+81.1%	+12.7%	+1221.5%
NTLAIntellia Therapeutics, Inc.	$1.5B	+0.1%	+44.5%	+57.7%	—	-69.7%	-81.3%	-39.8%
BEAMBeam Therapeutics Inc.	$3.0B	+19.3%	+6.5%	+45.8%	—	-14.1%	-60.5%	+54.1%

Compare:DYN vs SRPT DYN vs CRSP DYN vs BMRN DYN vs SRPT vs CRSP

About DYN Dividend Returns

Dyne Therapeutics, Inc. (DYN) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of DYN over the past year?

Dyne Therapeutics, Inc. (DYN) delivered a return of 47.68% over the past year. Since DYN does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in DYN be worth today?

A $10,000 investment in Dyne Therapeutics, Inc. one year ago would be worth $14,768 today, representing a gain of $4,768.

Q3Does DYN pay dividends?

Dyne Therapeutics, Inc. (DYN) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For DYN, the total return equals the price-only return.

Q4Did DYN beat the S&P 500?

Yes, Dyne Therapeutics, Inc. (DYN) outperformed the S&P 500 by 19.24 percentage points over the past year. DYN delivered a total return of 47.68%, compared to the S&P 500's 28.44%. This 19.24pp alpha means investors in DYN earned more than a passive S&P 500 index fund.

Q5What is DYN's worst drawdown?

Dyne Therapeutics, Inc. (DYN) experienced a maximum drawdown of -44.65% over the past year, declining from its peak on 2025-06-10 to its trough on 2025-07-07. The stock recovered to its prior peak by 2025-10-14. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is DYN's long-term total return over 10, 20, or 30 years?

Here are Dyne Therapeutics, Inc. (DYN)'s long-term returns with dividends reinvested. Over 10 years, the total return is -26.9% (-3.1% CAGR) — $10,000 would have grown to $7,310. Over 20 years: -26.9% total return (-1.6% CAGR) — $10,000 → $7,310. Over 30 years: -26.9% total return (-1.0% CAGR) — $10,000 → $7,310. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was DYN's best and worst year?

Dyne Therapeutics, Inc.'s best calendar year was 2024 with a total return of 80.4%. Its worst year was 2021 with a total return of -37.5%. This range shows the volatility investors should expect — the difference between the best and worst year is 117.9 percentage points.